Goodwill in USD of MYRIAD GENETICS INC from Q2 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
MYRIAD GENETICS INC quarterly Goodwill history and change rate from Q2 2011 to Q3 2025.
  • MYRIAD GENETICS INC Goodwill for the quarter ending 30 Sep 2025 was $51.6M, a 82% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

MYRIAD GENETICS INC Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $51.6M -$235M -82% 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 $51.6M -$235M -82% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $286M -$700K -0.24% 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $286M -$1.1M -0.38% 31 Dec 2024 10-Q 04 Nov 2025
Q3 2024 $286M -$300K -0.11% 30 Sep 2024 10-Q 08 Nov 2024
Q2 2024 $286M -$900K -0.31% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 $287M -$100K -0.04% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $287M +$600K +0.21% 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $287M +$50.1M +21.2% 30 Sep 2023 10-Q 07 Nov 2023
Q2 2023 $287M +$49.4M +20.8% 30 Jun 2023 10-Q 04 Aug 2023
Q1 2023 $287M +$48.3M +20.2% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $287M +$47.6M +19.9% 31 Dec 2022 10-K 28 Feb 2024
Q3 2022 $237M -$3.2M -1.34% 30 Sep 2022 10-Q 02 Nov 2022
Q2 2022 $238M -$2.3M -0.96% 30 Jun 2022 10-Q 05 Aug 2022
Q1 2022 $239M -$89.5M -27.3% 31 Mar 2022 10-Q 06 May 2022
Q4 2021 $239M -$90M -27.3% 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 $240M -$88.6M -27% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $240M -$87.5M -26.7% 30 Jun 2021 10-Q 04 Aug 2021
Q1 2021 $328M +$1.2M +0.37% 31 Mar 2021 10-Q 05 May 2021
Q4 2020 $329M -$78.9M -19.3% 31 Dec 2020 10-K 25 Feb 2022
Q3 2020 $328M -$87.8M -21.1% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $328M -$89.6M -21.5% 30 Jun 2020 10-KT 16 Mar 2021
Q1 2020 $327M -$88.8M -21.4% 31 Mar 2020 10-Q 06 May 2020
Q4 2019 $408M -$5.1M -1.23% 31 Dec 2019 10-Q 07 Feb 2020
Q3 2019 $416M +$2.8M +0.68% 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $417M +$98.6M +30.9% 30 Jun 2019 10-KT 16 Mar 2021
Q1 2019 $416M +$95.7M +29.9% 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $413M +$93.8M +29.4% 31 Dec 2018 10-Q 06 Feb 2019
Q3 2018 $413M +$94.3M +29.6% 30 Sep 2018 10-Q 07 Nov 2018
Q2 2018 $319M +$2.5M +0.79% 30 Jun 2018 10-KT 16 Mar 2021
Q1 2018 $320M +$5.2M +1.65% 31 Mar 2018 10-Q 09 May 2018
Q4 2017 $319M +$4M +1.27% 31 Dec 2017 10-Q 07 Feb 2018
Q3 2017 $319M +$6.2M +1.98% 30 Sep 2017 10-Q 08 Nov 2017
Q2 2017 $316M +$121M +61.9% 30 Jun 2017 10-K 13 Aug 2019
Q1 2017 $315M +$137M +77.1% 31 Mar 2017 10-Q 03 May 2017
Q4 2016 $315M +$138M +78.2% 31 Dec 2016 10-Q 08 Feb 2017
Q3 2016 $313M +$136M +76.4% 30 Sep 2016 10-Q 02 Nov 2016
Q2 2016 $195M +$18.1M +10.2% 30 Jun 2016 10-K 24 Aug 2018
Q1 2016 $178M -$7.33M -3.96% 31 Mar 2016 10-Q 04 May 2016
Q4 2015 $177M +$7.82M +4.62% 31 Dec 2015 10-Q 03 Feb 2016
Q3 2015 $177M +$8.12M +4.8% 30 Sep 2015 10-Q 04 Nov 2015
Q2 2015 $177M +$8M +4.73% 30 Jun 2015 10-K 09 Aug 2017
Q1 2015 $185M +$18.5M +11.1% 31 Mar 2015 10-Q 06 May 2015
Q4 2014 $169M +$112M +198% 31 Dec 2014 10-Q 04 Feb 2015
Q3 2014 $169M +$112M +198% 30 Sep 2014 10-Q 05 Nov 2014
Q2 2014 $169M +$112M +197% 30 Jun 2014 10-K 10 Aug 2016
Q1 2014 $167M +$110M +193% 31 Mar 2014 10-Q 07 May 2014
Q4 2013 $56.9M $0 0% 31 Dec 2013 10-Q 05 Feb 2014
Q3 2013 $56.9M $0 0% 30 Sep 2013 10-Q 12 Nov 2013
Q2 2013 $56.9M +$50K +0.09% 30 Jun 2013 10-K 12 Aug 2015
Q1 2013 $56.9M $0 0% 31 Mar 2013 10-Q 08 May 2013
Q4 2012 $56.9M $0 0% 31 Dec 2012 10-Q 06 Feb 2013
Q3 2012 $56.9M $0 0% 30 Sep 2012 10-Q 09 Nov 2012
Q2 2012 $56.9M +$799K +1.43% 30 Jun 2012 10-K 13 Aug 2014
Q1 2012 $56.9M 31 Mar 2012 10-Q 02 May 2012
Q4 2011 $56.9M 31 Dec 2011 10-Q 01 Feb 2012
Q3 2011 $56.9M 30 Sep 2011 10-Q 02 Nov 2011
Q2 2011 $56.1M 30 Jun 2011 10-K 15 Aug 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.